Amid the turbulence of the wider global economy in recent years, the pharmaceuticals industry is weathering its own storms. The rising cost of raw materials and supply chain disruptions are squeezing margins as pharma companies face intense pressure—including from countries like the US—to control drug costs. At the same time, a wave of expiring patents threatens…

Technology Review, published by MIT, is a leading source of news, analysis, and commentary on emerging technologies, scientific advancements, and their societal impacts. Covering topics such as artificial intelligence, biotechnology, renewable energy, and more, Technology Review provides  reporting and  articles on the intersection of technology and society. Readers can stay informed about the latest breakthroughs and trends shaping the future of technology.

MIT Technology Review

Pharmaceutical companies face mounting pressures from patent cliffs threatening $300 billion in sales by 2030, rising drug development costs reaching $4 billion per launch, and declining access to healthcare professionals. Agentic AI systems offer solutions by automating workflows across sales, compliance, and content review processes, enabling personalized communication at scale while managing the growing volume of materials requiring medical, legal, and regulatory approval.

Transforming commercial pharma with agentic AI